Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 3Thoracic 1Gastrointestinal 1

Conditions

Venous Thromboembolism 3Neoplasms 2Venous Thrombosis 1Lung Neoplasms 1Esophageal Neoplasms 1

Interventions

apixaban 22Rivaroxaban 16Dalteparin 16Enoxaparin 11Heparin, Low-Molecular-Weight 10Tinzaparin 8Aspirin 8Fondaparinux 4Dabigatran 4edoxaban 3Warfarin 3Nadroparin 3bemiparin 2abelacimab 2Rosuvastatin Calcium 2Observation 2MAA868 2sotorasib 1ribociclib 1reviparin 1palbociclib 1isoquercitrin 1enoxaparin sodium 1certoparin 1calcium heparin 1betrixaban 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Venous Thromboembolism × Nadroparin × Classical hematology × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

NCT00303407 2006-03-16

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

University Hospital, Geneva

Terminated
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡